MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 5.540
- -0.130-2.29%
Trading Dec 13 11:56 ET
338.90MMarket Cap-0.99P/E (TTM)
5.720High5.490Low833.95KVolume5.660Open5.670Pre Close4.66MTurnover1.73%Turnover RatioLossP/E (Static)61.17MShares28.26052wk High0.61P/B267.86MFloat Cap4.62052wk Low--Dividend TTM48.35MShs Float195.970Historical High--Div YieldTTM4.06%Amplitude4.620Historical Low5.590Avg Price1Lot Size
About Sage Therapeutics Company
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.
Company Profile
SymbolSAGE
Company NameSage Therapeutics
Listing DateJul 18, 2014
Issue Price18.00
Founded2010
CEOMr. Barry E. Greene
MarketNASDAQ
Employees487
Fiscal Year Ends12-31
Address55 Cambridge Parkway
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-299-8380
Websitehttp://www.sagerx.com
Company Executives
- Name
- Position
- Salary
- Barry E. Greene
- Director, President and Chief Executive Officer
- 6.24M
- Christopher Benecchi
- Chief Operating Officer, Treasurer, Principal Financial and Accounting Officer
- 2.28M
- Laura Gault, M.D.,PhD
- Chief Medical Officer
- 1.27M
- Dr. Jeffrey M. Jonas,M.D.
- Director
- 496.54K
- Geno J. Germano
- Independent Director
- 417.55K
- Dr. George S. Golumbeski, PhD
- Independent Director
- 412.55K
- James M. Frates
- Independent Director
- 435.05K
- Dr. Steven M. Paul, M.D.
- Independent Director
- 420.05K
- Jessica J. Federer
- Independent Director
- 962.23K
- Michael F. Cola
- Independent Director
- 440.05K
- Elizabeth Barrett
- Independent Director
- 425.05K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.